Ascletis to Present Study Results at ObesityWeek 2025 Ascletis Pharma Inc. announces multiple poster presentations of its obesity assets, including ASC30, ASC30 Injection, and the combinat…
Accident Attorney Leader in Spot TV A specialist in accident attorney services with roots in Florida has topped the most-seen spot report …
Kyverna Therapeutics, Inc. Kyverna Therapeutics Highlights Potential of KYV-101 in Rheumatoid Arthritis with Phase 1 Data from Investigato…
Qatar Museums Unveils Three Major Exhibitions Qatar Museums has opened three major exhibitions at M7, showcasing regional and global creat…
Amphista Therapeutics Achieves Breakthrough in Cancer Target Degradation Amphista Therapeutics, a leader in next-generation targeted prote…
Supreme Court's National Task Force And Constitutionalisation Of Student Mental Health On World Mental Health Day, while global efforts fo…
SAHPRA Approves Lenacapavir For HIV Prevention SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expecte…
FTSE Mixed as UK Lags Global Rally London stocks opened mixed on Monday, with the FTSE 100 edging up 0.1% to 9,651.66 as the UK market lag…
WKU Soccer Wins CUSA Regular Season Crown Western Kentucky University's soccer team secured the 2025 CUSA Regular Season Co-Championship w…
Cullinan Therapeutics Shares Preclinical Data for CLN-978 Cullinan Therapeutics, Inc. (Nasdaq: CGEM) presented new preclinical data for CL…
SAHPRA Approves Groundbreaking HIV Prevention Injection The South African Health Products Regulatory Authority (SAHPRA) has approved a new…